Brain MRI activity during the year before pregnancy can predict long-term clinical worsening in patients with Multiple Sclerosis.

Annualized relapse rate Magnetic resonance imaging Multiple sclerosis Post-partum relapses Pregnancy Relapse

Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 23 02 2023
accepted: 08 06 2023
pubmed: 26 6 2023
medline: 26 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

Pregnancy has been observed to reduce the frequency of relapses in Multiple Sclerosis (MS) patients, but the relapse risk tends to increase during the early post-partum period. Increased pre- and post-partum disease activity may predict a poor long-term prognosis. This study aimed to evaluate the correlation between magnetic resonance imaging (MRI) activity during the year before pregnancy and long-term clinically meaningful worsening in Expanded Disability Status Scale (EDSS). This observational, retrospective, case-control study included 141 pregnancies in 99 females with MS. Statistical analyses were used to evaluate the correlation between MRI activity during the year pre-pregnancy and post-partum clinical worsening during a 5-year follow-up. Clustered logistic regression was used to investigate the predictors of 5-year clinically meaningful worsening in EDSS (lt-EDSS). We found a significant correlation between an active MRI pre-pregnancy and lt-EDSS (p = 0.0006). EDSS pre-pregnancy and lt-EDSS were also significantly correlated (p = 0.043). Using a multivariate model, we predicted which females would not experience long-term clinical deterioration by a stable MRI pre-pregnancy (92.7% specificity; p = 0.004). An active MRI pre-conception is a strong predictor of lt-EDSS and a higher annual relapse rate during the follow-up period, regardless of whether the female had clinical evidence of disease activity prior to conception and delivery. Optimizing disease control and achieving imaging stability prior to conception may reduce the risk of long-term clinical deterioration.

Sections du résumé

BACKGROUND BACKGROUND
Pregnancy has been observed to reduce the frequency of relapses in Multiple Sclerosis (MS) patients, but the relapse risk tends to increase during the early post-partum period. Increased pre- and post-partum disease activity may predict a poor long-term prognosis. This study aimed to evaluate the correlation between magnetic resonance imaging (MRI) activity during the year before pregnancy and long-term clinically meaningful worsening in Expanded Disability Status Scale (EDSS).
METHODS METHODS
This observational, retrospective, case-control study included 141 pregnancies in 99 females with MS. Statistical analyses were used to evaluate the correlation between MRI activity during the year pre-pregnancy and post-partum clinical worsening during a 5-year follow-up. Clustered logistic regression was used to investigate the predictors of 5-year clinically meaningful worsening in EDSS (lt-EDSS).
RESULTS RESULTS
We found a significant correlation between an active MRI pre-pregnancy and lt-EDSS (p = 0.0006). EDSS pre-pregnancy and lt-EDSS were also significantly correlated (p = 0.043). Using a multivariate model, we predicted which females would not experience long-term clinical deterioration by a stable MRI pre-pregnancy (92.7% specificity; p = 0.004).
CONCLUSIONS CONCLUSIONS
An active MRI pre-conception is a strong predictor of lt-EDSS and a higher annual relapse rate during the follow-up period, regardless of whether the female had clinical evidence of disease activity prior to conception and delivery. Optimizing disease control and achieving imaging stability prior to conception may reduce the risk of long-term clinical deterioration.

Identifiants

pubmed: 37358691
doi: 10.1007/s10072-023-06909-3
pii: 10.1007/s10072-023-06909-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3989-3996

Informations de copyright

© 2023. Fondazione Società Italiana di Neurologia.

Références

Hellwig K (2014) Pregnancy in Multiple Sclerosis Fertility and Infertility in MS. Eur Neurol. https://doi.org/10.1159/000367640
doi: 10.1159/000367640 pubmed: 25278125
Filippi M, Rocca MA, De Stefano N et al (2011) Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol. https://doi.org/10.1001/archneurol.2011.914
Lassmann H, Brück W, Lucchinetti C, Rodriguez M (1997) Remyelination in multiple sclerosis. Mult Scler. https://doi.org/10.1177/1352458597003002
Brück W, Bitsch A, Kolenda H et al (1997) Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol. https://doi.org/10.1002/ana.410420515
doi: 10.1002/ana.410420515 pubmed: 9392578
Miller DH, Grossman RI, Reingold SC, McFarland HF (1998) The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain. https://doi.org/10.1093/brain/121.1.3
Van Walderveen MAA, Kamphorst W, Scheltens P et al (1998) Histopathologic correlate of hypointense lesions on T1-weighted spin- echo MRI in multiple sclerosis. Neurology. https://doi.org/10.1212/WNL.50.5.1282
doi: 10.1212/WNL.50.5.1282 pubmed: 9595975
Filippi M, Yousry T, Baratti C et al (1996) Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain. https://doi.org/10.1093/brain/119.4.1349
doi: 10.1093/brain/119.4.1349 pubmed: 8813296
Lehmann H, Zveik O, Levin N et al (2021) Brain MRI activity during the year before pregnancy can predict post-partum clinical relapses. Mult Scler J 1–8. https://doi.org/10.1177/13524585211002719
Anderson A, Krysko KM, Rutatangwa A et al (2021) Clinical and Radiologic Disease Activity in Pregnancy and Postpartum in MS. Neurol (R) Neuroimmunol Neuroinflammation. https://doi.org/10.1212/NXI.0000000000000959
doi: 10.1212/NXI.0000000000000959
Bove R, Gilmore W (2018) Hormones and MS: risk factors, biomarkers, and therapeutic targets. Mult Scler. https://doi.org/10.1177/1352458517737396
doi: 10.1177/1352458517737396 pubmed: 30346219
Langer-Gould AM (2019) Pregnancy and family planning in multiple sclerosis. CONTINUUM Lifelong Learn Neurol. https://doi.org/10.1212/CON.0000000000000745
Confavreux C, Hutchinson M, Hours MM et al (1998) Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. https://doi.org/10.1056/NEJM199807303390501
doi: 10.1056/NEJM199807303390501 pubmed: 9682040
Voskuhl R, Momtazee C (2017) Pregnancy: effect on multiple sclerosis, treatment considerations, and breastfeeding. Neurotherapeutics. https://doi.org/10.1007/s13311-017-0562-7
Vukusic S, Hutchinson M, Hours M et al (2004) Pregnancy and multiple sclerosis (the PRIMS study): Clinical predictors of post-partum relapse. Brain. https://doi.org/10.1093/brain/awh152
doi: 10.1093/brain/awh152 pubmed: 15130950
Simone IL, Tortorella C, Ghirelli A (2021) Influence of pregnancy in multiple sclerosis and impact of disease-modifying therapies. Front Neurol. https://doi.org/10.3389/fneur.2021.697974
Portaccio E, Tudisco L, Pastò L et al (2022) Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening. Mult Scler J. https://doi.org/10.1177/13524585211023365
doi: 10.1177/13524585211023365
Achiron A, Ben-David A, Gurevich · Michael, et al (2020) Parity and disability progression in relapsing-remitting multiple sclerosis. J Neurol 267:3753–3762. https://doi.org/10.1007/s00415-020-10093-1
doi: 10.1007/s00415-020-10093-1 pubmed: 32725314
Nguyen AL, Eastaugh A, van der Walt A, Jokubaitis VG (2019) Pregnancy and multiple sclerosis: clinical effects across the lifespan. Autoimmun Rev. https://doi.org/10.1016/j.autrev.2019.102360
Andersen JB, Wandall-Holm MF, Andersen PK et al (2021) Pregnancy in women with MS: Impact on long-term disability accrual in a nationwide Danish Cohort. Mult Scler J. https://doi.org/10.1177/13524585211057767
doi: 10.1177/13524585211057767
Lorefice L, Fronza M, Fenu G et al (2022) Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study. Neurol Ther. https://doi.org/10.1007/s40120-021-00297-6
doi: 10.1007/s40120-021-00297-6 pubmed: 34714518
Hughes SE, Spelman T, Gray OM et al (2014) Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult Scler J. https://doi.org/10.1177/1352458513507816
doi: 10.1177/1352458513507816
Uher T, Kubala Havrdova E, Vodehnalova K et al (2022) Pregnancy-induced brain magnetic resonance imaging changes in women with multiple sclerosis. Eur J Neurol. https://doi.org/10.1111/ene.15245
doi: 10.1111/ene.15245 pubmed: 35015921
McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. https://doi.org/10.1002/ana.1032
doi: 10.1002/ana.1032 pubmed: 11456302
Cree BAC, Hollenbach JA, Bove R et al (2019) Silent progression in disease activity–free relapsing multiple sclerosis. Ann Neurol. https://doi.org/10.1002/ana.25463
doi: 10.1002/ana.25463 pubmed: 31486104 pmcid: 7135931
Moccia M, Affinito G, Fumo MG et al (2023) Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020. J of Neurol Neurosurg Psych. https://doi.org/10.1136/jnnp-2022-330883
Ramachandran S, Strange RC, Kalra S et al (2013) Progression of disability in multiple sclerosis: A study of factors influencing median time to reach an EDSS value. Mult Scler Relat Disord. https://doi.org/10.1016/j.msard.2012.09.004
doi: 10.1016/j.msard.2012.09.004 pubmed: 25877632
Jokubaitis VG, Spelman T, Kalincik T et al (2016) Predictors of long-term disability accrual in relapse-onset multiple sclerosis. Ann Neurol. https://doi.org/10.1002/ana.24682
doi: 10.1002/ana.24682 pubmed: 27145331
Kearney H, Cahalane AM, Killeen RP, McGuigan C (2018) MRI and multiple sclerosis—the evolving role of MRI in the diagnosis and management of MS: a clinician’s perspective. Ir J Med Sci. https://doi.org/10.1007/s11845-017-1691-z
Harris JO, Frank JA, Patronas N et al (1991) Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history. Ann Neurol. https://doi.org/10.1002/ana.410290515
doi: 10.1002/ana.410290515 pubmed: 1859184
Alroughani R, Akhtar S, Zeineddine M et al (2019) Risk of relapses during pregnancy among multiple sclerosis patients. Mult Scler Relat Disord. https://doi.org/10.1016/j.msard.2019.06.007
doi: 10.1016/j.msard.2019.06.007 pubmed: 32164911
Berenguer-Ruiz L, Gimenez-Martinez J, Palazón-Bru A, Sempere AP (2019) Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy. J Neurol. https://doi.org/10.1007/s00415-019-09450-6
doi: 10.1007/s00415-019-09450-6 pubmed: 31256279
Meinl I, Havla J, Kümpfel T, Hohlfeld R (2018) Recurrence of disease activity during pregnancy after cessation of fingolimod in multiple sclerosis. Mult Scler J. https://doi.org/10.1177/1352458517731913
doi: 10.1177/1352458517731913
Alroughani R, Alowayesh MS, Ahmed SF et al (2018) Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era. Neurology. https://doi.org/10.1212/wnl.0000000000005065
doi: 10.1212/wnl.0000000000005065 pubmed: 29523094 pmcid: 5845207
Bsteh G, Hegen H, Riedl K et al (2022) Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score. Front Neurol. https://doi.org/10.3389/fneur.2021.766956
doi: 10.3389/fneur.2021.766956 pubmed: 35959383 pmcid: 9360751
Bsteh G, Algrang L, Hegen H et al (2020) Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria. Mult Scler J. https://doi.org/10.1177/1352458518816614
doi: 10.1177/1352458518816614
Langer-Gould A, Smith JB, Albers KB et al (2020) Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort. Neurology. https://doi.org/10.1212/WNL.0000000000009374
doi: 10.1212/WNL.0000000000009374 pubmed: 32284359 pmcid: 7274922
Leguy S, Lefort M, Lescot L et al (2022) COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients. J Neurol. https://doi.org/10.1007/s00415-022-11215-7
Krysko KM, Rutatangwa A, Graves J et al (2020) Association between breastfeeding and postpartum multiple sclerosis relapses: a systematic review and meta-analysis. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2019.4173

Auteurs

Shahar Kahila (S)

Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Neurology and Laboratory of Neuroimmunology, The Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Ein-Kerem, P.O.B. 12000, 91120, Jerusalem, Israel.
Department of Military Medicine and "Tzameret", Faculty of Medicine, Hebrew University of Jerusalem, and Medical Corps, Israel Defense Forces, Jerusalem, Israel.

Omri Zveik (O)

Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Neurology and Laboratory of Neuroimmunology, The Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Ein-Kerem, P.O.B. 12000, 91120, Jerusalem, Israel.

Netta Levin (N)

Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Neurology and Laboratory of Neuroimmunology, The Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Ein-Kerem, P.O.B. 12000, 91120, Jerusalem, Israel.

Livnat Brill (L)

Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Neurology and Laboratory of Neuroimmunology, The Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Ein-Kerem, P.O.B. 12000, 91120, Jerusalem, Israel.

Ariel Rechtman (A)

Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Neurology and Laboratory of Neuroimmunology, The Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Ein-Kerem, P.O.B. 12000, 91120, Jerusalem, Israel.

Nitzan Haham (N)

Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Neurology and Laboratory of Neuroimmunology, The Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Ein-Kerem, P.O.B. 12000, 91120, Jerusalem, Israel.

Tal Imbar (T)

Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Ein-Kerem, 91120, Jerusalem, Israel.

Adi Vaknin-Dembinsky (A)

Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Adembinsky@gmail.com.
Department of Neurology and Laboratory of Neuroimmunology, The Agnes-Ginges Center for Neurogenetics, Hadassah-Hebrew University Medical Center, Ein-Kerem, P.O.B. 12000, 91120, Jerusalem, Israel. Adembinsky@gmail.com.

Classifications MeSH